−195KRW
−20.37 BKRW
3.94 BKRW
80.27 M
About SILLAJEN
Sector
Industry
CEO
Eun-Sang Moon
Website
Headquarters
Jung-gu
Employees (FY)
43
Founded
2006
ISIN
KR7215600008
FIGI
BBG00F5P6RC6
SillaJen, Inc. develops oncolytic immunotherapeutics virus. Its products include pexa-vec and JX-929. The company was founded on March 28, 2006 and is headquartered in Busan, South Korea.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 215600 is 4 535 KRW — it has increased by 3.54% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange SILLAJEN stocks are traded under the ticker 215600.
Yes, you can track SILLAJEN financials in yearly and quarterly reports right on TradingView.
Like other stocks, 215600 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SILLAJEN stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 16, 2024, the company has 43.00 employees. See our rating of the largest employees — is SILLAJEN on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SILLAJEN EBITDA is −20.13 B KRW, and current EBITDA margin is −515.95%. See more stats in SILLAJEN financial statements.